Breaking Typhoon Dolphin Approaches Japan’s Southern Islands, Disrupting Travel and Prompting Evacuations U.S.-Mexico Border Wall Project Continues Over a Decade After Initial Pledge Indianapolis Colts Sign Jonathan Taylor to Two-Year Contract Extension FDA Approves First mRNA Flu Vaccine for Individuals 50 and Older Meta Ordered to Pay $567 Million for Youth Mental Health Impacts

Friday August 7, 2026

Reporter

Eli Lilly and Company

4Articles Published

5Communities Covered

Published Articles

Press Release

Lilly reports second-quarter 2026 financial results, raises full-year guidance, and highlights continued growth and pipeline progress

Aug 5

Press Release

Lilly’s olomorasib receives U.S. FDA’s Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer

Aug 3

Press Release

Lilly’s triple agonist, retatrutide, successful in two additional Phase 3 obesity trials, delivering significant improvements in weight and A1C

Jul 23

Press Release

Lilly confirms date and conference call for second-quarter 2026 financial results announcement

Jul 22